Cite

HARVARD Citation

    Visentin, A. et al. (2018). Dabigatran in ibrutinib‐treated patients with atrial fibrillation and lymphoproliferative diseases: Experience of 4 cases. Hematological oncology. 36 (5), pp. 801-803. [Online]. 
  
Back to record